Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Correlation Between Expression of Proteins That Are Essential for Embryonic Brain Development and Neurodevelopmental Outcomes at 2 Years of Age in Premature Infants.

NCT01686685 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT01686685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01686685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Correlation Between Expression of Proteins That Are Essential for Embryonic Brain Development and Neurodevelopmental Outcomes at 2 Years of Age in Premature Infants.
Lead sponsor
Hadassah Medical Organization
Phase
Observational
Overall status
Completed
Start date
September 30, 2013
Completion date
April 1, 2018
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder, complication of prematurity